nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—CASP3—tongue—salivary gland cancer	0.0284	0.101	CbGeAlD
Minocycline—CYCS—neck—salivary gland cancer	0.0191	0.068	CbGeAlD
Minocycline—CASP3—neck—salivary gland cancer	0.0163	0.0583	CbGeAlD
Minocycline—CASP1—connective tissue—salivary gland cancer	0.0142	0.0506	CbGeAlD
Minocycline—CYCS—connective tissue—salivary gland cancer	0.0137	0.0487	CbGeAlD
Minocycline—CASP1—epithelium—salivary gland cancer	0.0135	0.0481	CbGeAlD
Minocycline—CASP3—parotid gland—salivary gland cancer	0.0133	0.0474	CbGeAlD
Minocycline—CYCS—epithelium—salivary gland cancer	0.013	0.0463	CbGeAlD
Minocycline—CASP3—connective tissue—salivary gland cancer	0.0117	0.0417	CbGeAlD
Minocycline—CASP3—epithelium—salivary gland cancer	0.0111	0.0396	CbGeAlD
Minocycline—MMP9—neck—salivary gland cancer	0.0109	0.0388	CbGeAlD
Minocycline—CASP1—lymphoid tissue—salivary gland cancer	0.0104	0.037	CbGeAlD
Minocycline—CYCS—lymphoid tissue—salivary gland cancer	0.00999	0.0356	CbGeAlD
Minocycline—IL1B—connective tissue—salivary gland cancer	0.00935	0.0334	CbGeAlD
Minocycline—IL1B—epithelium—salivary gland cancer	0.00888	0.0317	CbGeAlD
Minocycline—CASP3—lymphoid tissue—salivary gland cancer	0.00856	0.0305	CbGeAlD
Minocycline—MMP9—connective tissue—salivary gland cancer	0.00779	0.0278	CbGeAlD
Minocycline—MMP9—epithelium—salivary gland cancer	0.0074	0.0264	CbGeAlD
Minocycline—IL1B—lymphoid tissue—salivary gland cancer	0.00684	0.0244	CbGeAlD
Minocycline—ALOX5—connective tissue—salivary gland cancer	0.00616	0.022	CbGeAlD
Minocycline—CASP1—lymph node—salivary gland cancer	0.00586	0.0209	CbGeAlD
Minocycline—MMP9—lymphoid tissue—salivary gland cancer	0.0057	0.0203	CbGeAlD
Minocycline—CYCS—lymph node—salivary gland cancer	0.00564	0.0201	CbGeAlD
Minocycline—CASP3—lymph node—salivary gland cancer	0.00483	0.0172	CbGeAlD
Minocycline—ALOX5—lymphoid tissue—salivary gland cancer	0.0045	0.0161	CbGeAlD
Minocycline—IL1B—lymph node—salivary gland cancer	0.00386	0.0138	CbGeAlD
Minocycline—VEGFA—lymph node—salivary gland cancer	0.00379	0.0135	CbGeAlD
Minocycline—MMP9—lymph node—salivary gland cancer	0.00321	0.0115	CbGeAlD
Minocycline—ALOX5—lymph node—salivary gland cancer	0.00254	0.00907	CbGeAlD
Minocycline—CASP3—Apoptosis—TP53—salivary gland cancer	0.000499	0.000693	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGF16—salivary gland cancer	0.000497	0.00069	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—TP53—salivary gland cancer	0.00048	0.000667	CbGpPWpGaD
Minocycline—CASP1—Immune System—NUP62—salivary gland cancer	0.000476	0.000662	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—MAP2K2—salivary gland cancer	0.000476	0.000661	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TP53—salivary gland cancer	0.000474	0.000659	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.000474	0.000658	CbGpPWpGaD
Minocycline—IL1B—Leptin signaling pathway—HRAS—salivary gland cancer	0.000473	0.000657	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—TP53—salivary gland cancer	0.000468	0.00065	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.000465	0.000647	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.000457	0.000635	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PHGDH—salivary gland cancer	0.000455	0.000632	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ISYNA1—salivary gland cancer	0.000454	0.00063	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—ATM—salivary gland cancer	0.000444	0.000617	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—HRAS—salivary gland cancer	0.000443	0.000616	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00044	0.000612	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ST3GAL4—salivary gland cancer	0.000438	0.000608	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.000437	0.000608	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.000436	0.000606	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—MAP2K2—salivary gland cancer	0.000432	0.0006	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—MAP2K2—salivary gland cancer	0.000427	0.000593	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.000425	0.00059	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—PIK3CA—salivary gland cancer	0.000418	0.000581	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TP53—salivary gland cancer	0.000415	0.000576	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—HRAS—salivary gland cancer	0.000412	0.000572	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—HRAS—salivary gland cancer	0.000409	0.000568	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—CDH1—salivary gland cancer	0.000406	0.000565	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000405	0.000563	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TP53—salivary gland cancer	0.000401	0.000557	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CCND1—salivary gland cancer	0.0004	0.000556	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—PIK3CA—salivary gland cancer	0.000399	0.000555	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000399	0.000555	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—MYB—salivary gland cancer	0.000398	0.000553	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AQP1—salivary gland cancer	0.000397	0.000552	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000392	0.000545	CbGpPWpGaD
Minocycline—VEGFA—Integrins in angiogenesis—PIK3CA—salivary gland cancer	0.000391	0.000543	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—WNT5B—salivary gland cancer	0.00039	0.000542	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—HRAS—salivary gland cancer	0.000387	0.000537	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.000384	0.000534	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CDH1—salivary gland cancer	0.000383	0.000532	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—PIK3CA—salivary gland cancer	0.000382	0.00053	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TP53—salivary gland cancer	0.00038	0.000528	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000379	0.000526	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—salivary gland cancer	0.000379	0.000526	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TP53—salivary gland cancer	0.000378	0.000525	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL17RD—salivary gland cancer	0.000376	0.000523	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.000376	0.000522	CbGpPWpGaD
Minocycline—IL1B—Immune System—DTX4—salivary gland cancer	0.000375	0.000522	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MARCKS—salivary gland cancer	0.00037	0.000514	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—TP53—salivary gland cancer	0.000369	0.000513	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—PIK3CA—salivary gland cancer	0.000368	0.000511	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000368	0.000511	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGFR4—salivary gland cancer	0.000367	0.00051	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—TP53—salivary gland cancer	0.000364	0.000505	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000361	0.000502	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—HRAS—salivary gland cancer	0.000361	0.000502	CbGpPWpGaD
Minocycline—CASP1—Immune System—FBXW7—salivary gland cancer	0.000361	0.000502	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—PIK3CA—salivary gland cancer	0.000358	0.000497	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—HRAS—salivary gland cancer	0.000353	0.000491	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—HRAS—salivary gland cancer	0.000353	0.00049	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000352	0.000489	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000349	0.000485	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—EP300—salivary gland cancer	0.000346	0.00048	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAML3—salivary gland cancer	0.000344	0.000478	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TP53—salivary gland cancer	0.000344	0.000478	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PYGB—salivary gland cancer	0.000344	0.000478	CbGpPWpGaD
Minocycline—IL1B—Immune System—CYLD—salivary gland cancer	0.00034	0.000472	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000336	0.000466	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—PTEN—salivary gland cancer	0.000335	0.000466	CbGpPWpGaD
Minocycline—IL1B—Immune System—PRKDC—salivary gland cancer	0.000326	0.000452	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MAP2K2—salivary gland cancer	0.000325	0.000451	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.00032	0.000444	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CREBBP—salivary gland cancer	0.000317	0.000441	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000317	0.00044	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NUP62—salivary gland cancer	0.000315	0.000438	CbGpPWpGaD
Minocycline—CYCS—Metabolism—VCAN—salivary gland cancer	0.000313	0.000435	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000312	0.000433	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—PIK3CA—salivary gland cancer	0.000312	0.000433	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGF16—salivary gland cancer	0.000311	0.000432	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—HRAS—salivary gland cancer	0.00031	0.000431	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MC3R—salivary gland cancer	0.000307	0.000426	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—salivary gland cancer	0.000305	0.000424	CbGpPWpGaD
Minocycline—CASP1—Immune System—FOXO3—salivary gland cancer	0.000305	0.000423	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—HRAS—salivary gland cancer	0.000303	0.00042	CbGpPWpGaD
Minocycline—IL1B—Immune System—NUP62—salivary gland cancer	0.000298	0.000414	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000295	0.00041	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—salivary gland cancer	0.000286	0.000398	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.000285	0.000397	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—PIK3CA—salivary gland cancer	0.000285	0.000396	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—ATM—salivary gland cancer	0.000284	0.000394	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—FOXO3—salivary gland cancer	0.000284	0.000394	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—CDH1—salivary gland cancer	0.000282	0.000392	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MAP2K2—salivary gland cancer	0.000282	0.000392	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PHGDH—salivary gland cancer	0.00028	0.000389	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00028	0.000389	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.000275	0.000383	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—PTEN—salivary gland cancer	0.000274	0.000381	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—WNT5B—salivary gland cancer	0.000271	0.000376	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ST3GAL4—salivary gland cancer	0.00027	0.000375	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—DTX4—salivary gland cancer	0.000268	0.000373	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000267	0.000371	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000266	0.00037	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—salivary gland cancer	0.000264	0.000367	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	0.000264	0.000366	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.000263	0.000365	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—HRAS—salivary gland cancer	0.000263	0.000365	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL17RD—salivary gland cancer	0.000261	0.000363	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000261	0.000363	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—salivary gland cancer	0.000259	0.00036	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000258	0.000359	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—PIK3CA—salivary gland cancer	0.000256	0.000356	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.000256	0.000356	CbGpPWpGaD
Minocycline—CASP1—Immune System—MAP2K2—salivary gland cancer	0.000249	0.000346	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—salivary gland cancer	0.000247	0.000344	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CREBBP—salivary gland cancer	0.000247	0.000343	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—FOXO3—salivary gland cancer	0.000246	0.000342	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AQP1—salivary gland cancer	0.000245	0.00034	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—PIK3CA—salivary gland cancer	0.000242	0.000336	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAML3—salivary gland cancer	0.000239	0.000332	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CCND1—salivary gland cancer	0.000237	0.00033	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—HRAS—salivary gland cancer	0.000237	0.000329	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000236	0.000329	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	0.000236	0.000329	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—WNT5B—salivary gland cancer	0.000235	0.000326	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MAP2K2—salivary gland cancer	0.000232	0.000322	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGFR4—salivary gland cancer	0.000229	0.000319	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—PTEN—salivary gland cancer	0.000229	0.000318	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000228	0.000317	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL17RD—salivary gland cancer	0.000227	0.000315	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—PTEN—salivary gland cancer	0.000226	0.000315	CbGpPWpGaD
Minocycline—IL1B—Immune System—FBXW7—salivary gland cancer	0.000226	0.000314	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—HRAS—salivary gland cancer	0.000224	0.000311	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000222	0.000309	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGF16—salivary gland cancer	0.000222	0.000308	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—HRAS—salivary gland cancer	0.000219	0.000304	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000218	0.000302	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EP300—salivary gland cancer	0.000216	0.0003	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MC3R—salivary gland cancer	0.000213	0.000296	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAML3—salivary gland cancer	0.000207	0.000288	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000205	0.000285	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MAP2K2—salivary gland cancer	0.000201	0.00028	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NUP62—salivary gland cancer	0.000194	0.00027	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—PIK3CA—salivary gland cancer	0.000193	0.000269	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—VCAN—salivary gland cancer	0.000193	0.000268	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAML2—salivary gland cancer	0.000193	0.000268	CbGpPWpGaD
Minocycline—IL1B—Immune System—FOXO3—salivary gland cancer	0.00019	0.000264	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NOTCH1—salivary gland cancer	0.00019	0.000264	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000188	0.000261	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DTX4—salivary gland cancer	0.000186	0.000259	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MC3R—salivary gland cancer	0.000185	0.000257	CbGpPWpGaD
Minocycline—CASP1—Immune System—CREBBP—salivary gland cancer	0.000185	0.000257	CbGpPWpGaD
Minocycline—CASP1—Immune System—CDH1—salivary gland cancer	0.000183	0.000255	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—HRAS—salivary gland cancer	0.000179	0.000249	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—PIK3CA—salivary gland cancer	0.000178	0.000247	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000178	0.000247	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CREBBP—salivary gland cancer	0.000172	0.000239	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000169	0.000235	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—EP300—salivary gland cancer	0.000168	0.000233	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NOTCH1—salivary gland cancer	0.000165	0.000229	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	0.000165	0.000229	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—JAG1—salivary gland cancer	0.000165	0.000229	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGFR4—salivary gland cancer	0.000164	0.000228	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—PIK3CA—salivary gland cancer	0.000162	0.000225	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DTX4—salivary gland cancer	0.000162	0.000225	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FBXW7—salivary gland cancer	0.000161	0.000224	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000161	0.000224	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—PIK3CA—salivary gland cancer	0.00016	0.000222	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000156	0.000216	CbGpPWpGaD
Minocycline—IL1B—Immune System—MAP2K2—salivary gland cancer	0.000155	0.000216	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF16—salivary gland cancer	0.000154	0.000214	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—HRAS—salivary gland cancer	0.00015	0.000208	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CREBBP—salivary gland cancer	0.000149	0.000208	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—HRAS—salivary gland cancer	0.000148	0.000205	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—CREBBP—salivary gland cancer	0.000147	0.000204	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.000143	0.000199	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FOXO3—salivary gland cancer	0.000136	0.000189	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000135	0.000188	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAML2—salivary gland cancer	0.000134	0.000186	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF16—salivary gland cancer	0.000134	0.000186	CbGpPWpGaD
Minocycline—CASP1—Immune System—PTEN—salivary gland cancer	0.000132	0.000183	CbGpPWpGaD
Minocycline—CASP1—Immune System—EP300—salivary gland cancer	0.000126	0.000175	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000123	0.000171	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CREBBP—salivary gland cancer	0.000122	0.00017	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000121	0.000168	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—salivary gland cancer	0.00012	0.000167	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EP300—salivary gland cancer	0.000117	0.000163	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAML2—salivary gland cancer	0.000116	0.000161	CbGpPWpGaD
Minocycline—IL1B—Immune System—CREBBP—salivary gland cancer	0.000115	0.00016	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000115	0.00016	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDH1—salivary gland cancer	0.000115	0.000159	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—JAG1—salivary gland cancer	0.000114	0.000159	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGFR4—salivary gland cancer	0.000114	0.000158	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—HRAS—salivary gland cancer	0.000112	0.000156	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FBXW7—salivary gland cancer	0.000112	0.000155	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAP2K2—salivary gland cancer	0.000111	0.000154	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000103	0.000143	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EP300—salivary gland cancer	0.000102	0.000141	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—EP300—salivary gland cancer	9.98e-05	0.000139	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—JAG1—salivary gland cancer	9.91e-05	0.000138	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGFR4—salivary gland cancer	9.87e-05	0.000137	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—HRAS—salivary gland cancer	9.76e-05	0.000136	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FBXW7—salivary gland cancer	9.71e-05	0.000135	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FOXO3—salivary gland cancer	9.44e-05	0.000131	CbGpPWpGaD
Minocycline—CASP1—Immune System—PIK3CA—salivary gland cancer	9.31e-05	0.000129	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOTCH1—salivary gland cancer	9.1e-05	0.000126	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTEN—salivary gland cancer	8.73e-05	0.000121	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	8.62e-05	0.00012	CbGpPWpGaD
Minocycline—CASP1—Immune System—HRAS—salivary gland cancer	8.61e-05	0.00012	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	8.52e-05	0.000118	CbGpPWpGaD
Minocycline—CYCS—Metabolism—EP300—salivary gland cancer	8.32e-05	0.000116	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CREBBP—salivary gland cancer	8.25e-05	0.000115	CbGpPWpGaD
Minocycline—IL1B—Immune System—PTEN—salivary gland cancer	8.24e-05	0.000115	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FOXO3—salivary gland cancer	8.19e-05	0.000114	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—HRAS—salivary gland cancer	8.02e-05	0.000111	CbGpPWpGaD
Minocycline—IL1B—Immune System—EP300—salivary gland cancer	7.86e-05	0.000109	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAP2K2—salivary gland cancer	7.71e-05	0.000107	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CREBBP—salivary gland cancer	7.53e-05	0.000105	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PIK3CA—salivary gland cancer	7.39e-05	0.000103	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—salivary gland cancer	7.14e-05	9.93e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—HRAS—salivary gland cancer	6.97e-05	9.68e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—HRAS—salivary gland cancer	6.83e-05	9.49e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAP2K2—salivary gland cancer	6.69e-05	9.3e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOTCH1—salivary gland cancer	6.31e-05	8.77e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3CA—salivary gland cancer	6.16e-05	8.56e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCND1—salivary gland cancer	6.1e-05	8.48e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTEN—salivary gland cancer	5.89e-05	8.18e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PIK3CA—salivary gland cancer	5.82e-05	8.08e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CREBBP—salivary gland cancer	5.72e-05	7.95e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EP300—salivary gland cancer	5.62e-05	7.8e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOTCH1—salivary gland cancer	5.48e-05	7.62e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—HRAS—salivary gland cancer	5.38e-05	7.48e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTEN—salivary gland cancer	5.38e-05	7.47e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—EP300—salivary gland cancer	5.13e-05	7.13e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CREBBP—salivary gland cancer	4.97e-05	6.91e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCND1—salivary gland cancer	4.24e-05	5.89e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3CA—salivary gland cancer	4.15e-05	5.77e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTEN—salivary gland cancer	4.09e-05	5.68e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—salivary gland cancer	4.02e-05	5.59e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EP300—salivary gland cancer	3.9e-05	5.42e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HRAS—salivary gland cancer	3.84e-05	5.34e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3CA—salivary gland cancer	3.79e-05	5.27e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCND1—salivary gland cancer	3.68e-05	5.11e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTEN—salivary gland cancer	3.55e-05	4.93e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EP300—salivary gland cancer	3.38e-05	4.7e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3CA—salivary gland cancer	2.88e-05	4.01e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—salivary gland cancer	2.79e-05	3.88e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HRAS—salivary gland cancer	2.67e-05	3.71e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3CA—salivary gland cancer	2.5e-05	3.48e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—salivary gland cancer	2.42e-05	3.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HRAS—salivary gland cancer	2.32e-05	3.22e-05	CbGpPWpGaD
